Masco Corp. (MAS) was upgraded to a Buy recommendation by TheStreet.com's quantitative service Wednesday. Let's check out the charts and indicators to see if we are both on the same page.



Masco Corp. (MAS) was upgraded to a Buy recommendation by TheStreet.com's quantitative service Wednesday. Let's check out the charts and indicators to see if we are both on the same page.
Bulls hoped that a bottom had been found, but they overlooked the reasons behind the rally last week.
The shares have been in the single digits since early May.
With an expected dip for 2023, the pharmaceutical company could see its mRNA technology win big over the long term -- and investors could be rewarded.
Let's check out the charts and indicators on this operator of casinos and racetracks.
We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.
Email Real Money's Wall Street Pros for further analysis and insight
Already a Subscriber? Login
Follow Real Money's Wall Street Pros to receive real-time investing alerts
Already a Subscriber? Login